Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CEPHALEXIN 125 | 125MG | POWDER FOR SUSPENSION | Resolved | 2024-01-25 | 2024-03-18 | 217220 |
TEVA-RISEDRONATE | 30MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-19 | 216497 |
TEVA-DILTIAZEM XC | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-18 | 2024-04-25 | 216466 |
RATIO-TOPISALIC | 20MG 0.5MG | LOTION | Actual shortage | 2024-01-18 | 2024-01-25 | 216463 |
TEVA-GLYBURIDE | 2.5MG | TABLET | Actual shortage | 2024-01-18 | 2024-02-15 | 216460 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2024-01-18 | 2024-03-07 | 216457 |
ACT PIOGLITAZONE | 45MG | TABLET | Actual shortage | 2024-01-18 | 2024-01-18 | 216454 |
TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2024-01-11 | 2024-04-25 | 215760 |
TEVA-PERINDOPRIL/INDAPAMIDE | 2.5MG 8MG | TABLET | Resolved | 2024-01-11 | 2024-01-19 | 215757 |
TEVA-EVEROLIMUS | 2.5MG | TABLET | Actual shortage | 2024-01-11 | 2024-01-18 | 215754 |
TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215751 |
TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215746 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-02-22 | 215743 |
TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215740 |
ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-11 | 2024-04-11 | 215737 |
TEVA-TEMOZOLOMIDE | 140MG | CAPSULE | Actual shortage | 2024-01-11 | 2024-01-18 | 215734 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2024-01-11 | 2024-02-01 | 215731 |
TEVA-TELMISARTAN | 80MG | TABLET | Resolved | 2024-01-11 | 2024-04-25 | 215728 |
ACT QUETIAPINE | 200MG | TABLET | Resolved | 2024-01-11 | 2024-04-11 | 215725 |
TEVA-SIMVASTATIN | 40MG | TABLET | Actual shortage | 2024-01-11 | 2024-04-18 | 215722 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |